Details for Australian Trade Mark No. 1109849 (hide)

Owner Cell Therapeutics, Inc.

Convention US 28 March 2006 78/848366

Service Freehills

Various Advertisement of a series of trade marks. Convention priority claimed: 28 March 2006, United States of America, No. 78/848366 in respect of PHARMACEUTICALS, NAMELY DRUGS FOR USE IN THE TREATMENT OF CANCER in Class 5.* The first coloured trade mark in the

Filing Date 20 April 2006

Classes

Class 5 Pharmaceuticals, including drugs for use in the treatment of cancer

Event Publications

11 May 2006 Application filed

27 July 2006 Application Accepted

30 November 2006 Trade Mark Registered/Protected

12 July 2007 Subsequent Owners/Holder Registered - Full Assignment

  Cell Therapeutics, Inc. is the full asignee of Novartis AG.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1109850-CUGGLES

1109848-MC PETER SWITZER MONEY COACH